Animal models of human disease

Citations 91-100 of 960 total displayed.

Past content (since Jan 1999):

Research Letters
Upregulation of Macrophage Migration Inhibitory Factor Gene Expression in Stroke

Lijuan Wang, Odysseus Zis, Guixian Ma, Zhixin Shan, Xiong Zhang, Shuo Wang, Chengbo Dai, Jiehao Zhao, Qiuxiong Lin, Shuguang Lin, and Weihong Song
Stroke 2009;40:973-976; published online before print as doi:10.1161/STROKEAHA.108.530535 [Abstract] [Full text]  

Articles
Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations

Marc Fisher, Giora Feuerstein, David W. Howells, Patricia D. Hurn, Thomas A. Kent, Sean I. Savitz, Eng H. Lo for the STAIR Group
Stroke published February 26, 2009, doi:10.1161/STROKEAHA.108.541128 [Abstract]  

Articles
SK_Ca and IK_Ca Channels, Myogenic Tone, and Vasodilator Responses in Middle Cerebral Arteries and Parenchymal Arterioles. Effect of Ischemia and Reperfusion

Marilyn J. Cipolla, Jeremiah Smith, Meghan M. Kohlmeyer, and Julie A. Godfrey
Stroke published February 26, 2009, doi:10.1161/STROKEAHA.108.535435 [Abstract]  

Articles
Angiotensin AT₂ Receptor Stimulation Causes Neuroprotection in a Conscious Rat Model of Stroke

Claudia A. McCarthy, Antony Vinh, Jennifer K. Callaway, and Robert E. Widdop
Stroke published February 26, 2009, doi:10.1161/STROKEAHA.108.531509 [Abstract]  

Articles
Thrombin Inhibition by Argatroban Ameliorates Early Brain Injury and Improves Neurological Outcomes After Experimental Subarachnoid Hemorrhage in Rats

Takashi Sugawara, Vikram Jadhav, Robert Ayer, Wanqiu Chen, Hidenori Suzuki, and John H. Zhang
Stroke published February 19, 2009, doi:10.1161/STROKEAHA.108.531699 [Abstract]  

Articles
Ultrafast High-Resolution In Vivo Volume-CTA of Mice Cerebral Vessels

Sebastian J. Schambach, Simona Bag, Volker Steil, Cristina Isaza, Lothar Schilling, Christoph Groden, and Marc A. Brockmann
Stroke published February 12, 2009, doi:10.1161/STROKEAHA.108.521740 [Abstract]  

Original Contributions
Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): Bridging Basic and Clinical Science for Cellular and Neurogenic Factor Therapy in Treating Stroke

The STEPS Participants
Stroke 2009;40:510-515; published online before print as doi:10.1161/STROKEAHA.108.526863 [Abstract] [Full text]  

Original Contributions
Methodological Quality of Animal Studies of Neuroprotective Agents Currently in Phase II/III Acute Ischemic Stroke Trials

Maria Philip, Michael Benatar, Marc Fisher, and Sean I. Savitz
Stroke 2009;40:577-581; published online before print as doi:10.1161/STROKEAHA.108.524330 [Abstract] [Full text]  

Original Contributions
Exaggeration of Focal Cerebral Ischemia in Transgenic Mice Carrying Human Renin and Human Angiotensinogen Genes

Shinji Inaba, Masaru Iwai, Yumiko Tomono, Izumi Senba, Megumi Furuno, Harumi Kanno, Hideki Okayama, Masaki Mogi, Jitsuo Higaki, and Masatsugu Horiuchi
Stroke 2009;40:597-603; published online before print as doi:10.1161/STROKEAHA.108.519801 [Abstract] [Full text]  

Original Contributions
Protective Effect of Delayed Treatment With Low-Dose Glibenclamide in Three Models of Ischemic Stroke • Supplemental Methods

J. Marc Simard, Vladimir Yurovsky, Natalia Tsymbalyuk, Ludmila Melnichenko, Svetlana Ivanova, and Volodymyr Gerzanich
Stroke 2009;40:604-609; published online before print as doi:10.1161/STROKEAHA.108.522409 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96